RO 23-6240 (AM-833), a new fluoroquinolone: In vitro antimicrobial activity and tentative disk diffusion interpretive criteria
- 1 May 1987
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 7 (1) , 29-35
- https://doi.org/10.1016/0732-8893(87)90066-6
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivativeAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of Ro 23-6240, a new fluorinated 4-quinoloneAntimicrobial Agents and Chemotherapy, 1986
- Proposed disk diffusion susceptibility criteria for ofloxacinJournal of Clinical Microbiology, 1985
- Evaluation of in vitro antibacterial activity of enoxacin: Comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limitsDiagnostic Microbiology and Infectious Disease, 1985
- In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strainsAntimicrobial Agents and Chemotherapy, 1980